Papilocare Mechanism of Action

Papilocare is a gel that acts by forming a film on the cervical mucosa, creating a defensive barrier to prevent the risk of HPV integration. In this way, it disrupts HPV integration (risk factor of pre-cancerous lesions progress to invasive cervical cancer), preventing the formation of new lesions, and also acts as to aid in re-epithelialising pre-existing lesions.
It also stimulates the regeneration of the vaginal microbiota.
Clinical Evidence: Several studies have been carried out with Papilocare that support its clinical efficacy and safety. In several studies performed by the manufacturer, improvement in cervical-vaginal mucosal re-epithelialisation was observed with the use of Papilocare. In a study comparing mucosal repair in untreated women and women treated with Papilocare, it was observed that in women using Papilocare, the percentage of women whose HPV-induced lesions were repaired was higher than for untreated women.
Other studies performed by independent investigators in university hospitals also confirmed the efficacy and safety of use of Papilocare.